» Articles » PMID: 38695473

Comparable Ventilatory Inefficiency at Maximal and Submaximal Performance in COPD Vs. CHF Subjects: An Innovative Approach

Abstract

Background: Currently, excess ventilation has been grounded under the relationship between minute-ventilation/carbon dioxide output ( V ˙ E - V ˙ CO 2 ). Alternatively, a new approach for ventilatory efficiency ( η E V ˙ ) has been published.

Objective: Our main hypothesis is that comparatively low levels of η E V ˙ between chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are attainable for a similar level of maximum and submaximal aerobic performance, conversely to long-established methods ( V ˙ E - V ˙ CO 2 slope and intercept).

Methods: Both groups performed lung function tests, echocardiography, and cardiopulmonary exercise testing. The significance level adopted in the statistical analysis was 5%. Thus, nineteen COPD and nineteen CHF-eligible subjects completed the study. With the aim of contrasting full values of V ˙ E - V ˙ CO 2 and η V ˙ E for the exercise period (100%), correlations were made with smaller fractions, such as 90% and 75% of the maximum values.

Results: The two groups attained matched characteristics for age (62±6 vs. 59±9 yrs, p>.05), sex (10/9 vs. 14/5, p>0.05), BMI (26±4 vs. 27±3 Kg m2, p>0.05), and peak V ˙ O 2 (72±19 vs. 74±20 %pred, p>0.05), respectively. The V ˙ E - V ˙ CO 2 slope and intercept were significantly different for COPD and CHF (27.2±1.4 vs. 33.1±5.7 and 5.3±1.9 vs. 1.7±3.6, p<0.05 for both), but η V ˙ E average values were similar between-groups (10.2±3.4 vs. 10.9±2.3%, p=0.462). The correlations between 100% of the exercise period with 90% and 75% of it were stronger for η V ˙ E (r>0.850 for both).

Conclusion: The η V ˙ E is a valuable method for comparison between cardiopulmonary diseases, with so far distinct physiopathological mechanisms, including ventilatory constraints in COPD.

Citing Articles

Ventilatory Efficiency: Is This the Key to Unlock the Full Potential of Cardiopulmonary Exercise Testing?.

Rossi A, Braga F, Stein R Arq Bras Cardiol. 2024; 121(4):e20240184.

PMID: 38865567 PMC: 11164441. DOI: 10.36660/abc.20240184.

References
1.
Van Laethem C, De Sutter J, Peersman W, Calders P . Intratest reliability and test-retest reproducibility of the oxygen uptake efficiency slope in healthy participants. Eur J Cardiovasc Prev Rehabil. 2009; 16(4):493-8. DOI: 10.1097/HJR.0b013e32832c88a8. View

2.
Hsia D, Casaburi R, Pradhan A, Torres E, Porszasz J . Physiological responses to linear treadmill and cycle ergometer exercise in COPD. Eur Respir J. 2009; 34(3):605-15. DOI: 10.1183/09031936.00069408. View

3.
ODonnell D, Elbehairy A, Faisal A, Webb K, Neder J, Mahler D . Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing. Eur Respir Rev. 2016; 25(141):333-47. PMC: 9487205. DOI: 10.1183/16000617.0054-2016. View

4.
Neder J, Berton D, Marillier M, Bernard A, ODonnell D . Inspiratory Constraints and Ventilatory Inefficiency Are Superior to Breathing Reserve in the Assessment of Exertional Dyspnea in COPD. COPD. 2019; 16(2):174-181. DOI: 10.1080/15412555.2019.1631776. View

5.
Corra U, Agostoni P, Anker S, Coats A, Crespo Leiro M, de Boer R . Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2017; 20(1):3-15. DOI: 10.1002/ejhf.979. View